Skip to main content

STEMPOINT CAPITAL LP

Position in IMVT — Immunovant, Inc.

CIK 1952142 NEW YORK, NY

Position in IMVT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$10,654,585
-$7,888,325 QoQ
Shares Held
276,527
-63.0% QoQ
Ownership
0.134%
of shares outstanding
% of Portfolio
1.84%
of 13F equity value
Holder Rank
#42
of 226 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority Sole 87% Shared 0% None 13%

Common Shares in IMVT Over Time

Shares Held

Position Value (USD)

Derivatives in IMVT

reported options exposure · as of Mar 31, 2026
CallValue
$255,000
CallShares
100,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

STEMPOINT CAPITAL LP holds $524,439,182 across 65 Biotechnology names. IMVT ranks #17 (2.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in IMVT

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $10,654,585 276,527
2026-03-31 $255,000 100,000
2026-03-31 $18,542,910 746,494
2025-12-31 $16,394,857 644,959
2025-09-30 $25,624,029 1,589,580
2025-09-30 $50,000 250,000
2025-06-30 $310,000 100,000
2025-06-30 $20,813,760 1,300,860
2025-03-31 $14,585,836 853,472
2024-12-31 $27,705,443 1,118,508
2024-09-30 $19,130,238 671,001
2024-09-30 $112,500 200,000
2024-06-30 $26,713,605 1,011,879
2024-03-31 $318,750 250,000
2024-03-31 $20,265,736 627,228
2023-12-31 $13,566,491 322,015